Additionally, research published in Drug Testing and Analysis characterizing AOD9604 metabolism and confirming its C-terminal HGH fragment structure, supporting its classification as a non-IGF-1-stimulating lipolytic agent has been used by clinicians evaluating the compound for metabolic applications
AOD 9604 does not share this risk profile
Preliminary studies suggest potential associations between 5-Amino-1MQ and mitochondrial outcomes, including investigations of biogenesis and cellular energy-related mechanisms
Phase 2 trials (Jastreboff et al., NEJM, 2023) have shown it to be highly effective for weight reduction in adults with obesity
These treatments can help boost your energy, improve mental clarity, and support healthy hair growthhelping you look and feel your best from the inside out
AOD 9604 peptide appeared to exhibit action similar to hGH wherein both may be capable of increasing repressed levels of lipolytic receptors in obese mice as compared to the lean mice